Effect of Rosiglitazone Adverse Effect on Bone Markers Reversed by Salvia Miltiorrhiza Extract
IAR Journal of Pharmacy · 10.09.2021 · 2 (2) · 1-4
DOI: 10.47310/iarjp.2021.v02i02.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift IAR Journal of Pharmacy, online erschienen am 10.09.2021. Verfasst von Yahya I Asiri und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Diabetes has been linked to an increased risk of osteoporosis-related fractures and osteoarthritis in recent years. Salvia miltiorrhiza Bunge (SME) extract has been shown to reduce bone damage in the past. However, whether SME can protect against antidiabetic drug induced bone loss is unknown. The effects of SME on bone oxidative stress and turnover markers in diabetic rats are investigated in this study. Diabetic Sprague Dawley rats (n = 6) were utilised to study streptozotocin (STZ) induced diabetes. Five groups of six Wistar albino rats were studied: control (vehicle therapy), Streptozotocin (diabetes) group and SME group, Rosiglitazone and Rosiglitazone +SME group. Each medication was given by gastric gavage once a day for 35 days. A healthy rat group was employed as a standard control group. As a normal control group, a healthy rat group was used. ELISA assays were used to detect insulin, oxidative stress and bone turnover indicators in the blood. SME treatment substantially increased insulin and osteocalcin levels in diabetic rats compared to diabetic control rats. By increasing osteogenesis and decreasing bone oxidative stress, SME may be able to prevent bone damage. These data support the use of SME as an osteoporosis treatment in diabetics.
Zitieren
APA
Asiri, Y. I., Asseri, K. A., Alqahtani, A., Venkatesan, K., Khan, N. A., Easwaran, V., Pappiya, E. M., Paulsam, P., Natarajan, R., Krishnaraju, K., Chidambaram, K., & Venkatesan, K. (2021). Effect of Rosiglitazone Adverse Effect on Bone Markers Reversed by Salvia Miltiorrhiza Extract. IAR Journal of Pharmacy, 2(2), 1-4. https://doi.org/10.47310/iarjp.2021.v02i02.010
Vancouver
Asiri YI, Asseri KA, Alqahtani A, Venkatesan K, Khan NA, Easwaran V, et al. Effect of Rosiglitazone Adverse Effect on Bone Markers Reversed by Salvia Miltiorrhiza Extract. IAR Journal of Pharmacy. 2021;2(2):1-4. doi:10.47310/iarjp.2021.v02i02.010
BibTeX
@article{Asiri2021,
author = {Asiri, Yahya I and Asseri, Khalid A and Alqahtani, Ali and Venkatesan, Krishnaraju and Khan, Noohu Abdulla and Easwaran, Vigneshwaran and Pappiya, Ester Mary and Paulsam, Premalatha and Natarajan, R. and Krishnaraju, Kalpana and Chidambaram, Kumarappan and Venkatesan, Kumar},
title = {Effect of Rosiglitazone Adverse Effect on Bone Markers Reversed by Salvia Miltiorrhiza Extract},
journal = {IAR Journal of Pharmacy},
year = {2021},
volume = {2},
number = {2},
pages = {1--4},
doi = {10.47310/iarjp.2021.v02i02.010}
}
EUVIMED